NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

CreditAccess Grameen (CREDAG) Research Report

Improving Operating Momentum and Resilient Portfolio Retention

CreditAccess Grameen (CREDAG) is emerging from the recent MFI stress phase with improving operating momentum, resilient portfolio retention, and a structurally stronger business mix. The normalization of asset quality trends, combined with retail finance-led diversification and improving spreads, positions the company for a sharp earnings recovery in FY27–28E.

Key Highlights

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

  • 70–80% of disbursements extended to existing customers, reflecting strong borrower stickiness
  • Retail finance share in AUM has risen from 11% to 14% in Dec'25
  • Management aims to achieve a balanced secured–unsecured mix within retail finance, strengthening portfolio diversification

Outlook

We model an AUM/NII/PPoP/PAT CAGR of 21%/16%/13%/50% over FY26–28E

  • RoA/RoE expected to improve to 4.5%/17.5% by FY28E
  • 2.3x FY27E P/BV valuation, with a BUY rating and Target Price of INR1,600 (premised on 2.4x Dec'27E BVPS)

Investor Takeaway

Investors should consider CreditAccess Grameen for potential earnings recovery.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.